Marlise Luskin, Hari Raman, Se Eun Kim, Daniel DeAngelo, Kristen Stevenson, Donna Neuberg, Eric Winer, Martha Wadleigh, Jacqueline Garcia, Annette Kim, Richard Stone, Vincent Ho
Rodrigo Fonseca, Mariano Arribas, Julia E. Wiedmeier-Nutor, Yael N. Kusne, Miguel Gonzalez-Velez, Heidi Kosiorek, Richard J. Butterfield, Ilan Kirsch, Joseph Mikhael, A. Keith Stewart, Craig Reeder, Jeremy Larsen, P. Bergsagel, Rafael Fonseca
Researchers in China have discovered that inhibiting a protein called the GABAA receptor can protect intestinal stem cells from the toxic effects of chemotherapy and radiotherapy. The study, published September 20 in the Journal of Experimental Medicine (JEM), suggests that the FDA-approved anti-sedative flumazenil, which targets GABAA receptors, could alleviate some of the common gastrointestinal side effects, such as diarrhea and vomiting, induced by many cancer treatments.
Kayla Madsen, Katherine Lee, Shiyi Chen, Carol Chen, Arjun Law, Armin Gerbitz, Rajat Kumar, Dennis Kim, Wilson Lam, Ivan Pasic, Auro Viswabandya, Fotios Michelis, Ram Vasudevan Nampoothiri, Jeffrey Lipton,
Christopher Jr Illingworth, Alexandra Y Kreins, Adriana Margarit Soler, Tim Best, Patricia Dyal, Giovanna Lucchini, Kanchan Rao, Rachel Williams, Austen Jj Worth, Judith Breuer